Professor Xenofon Baraliakos, EULAR president-elect, discusses personalised treatment and other challenges and opportunities ...

Study finds perioperative pembrolizumab plus neoadjuvant chemotherapy in early-stage NSCLC is safe, effective and improves ...

Professor Antonio Almeida shares plans for his EHA presidency, key takeaways from its Congress and thoughts on clinical ...

Switching to biosimilars when treating patients with haematological cancers does not increase the risk of adverse events, ...

A new ESPR survey examines how lung ultrasound is used in NICUs across Europe to better understand how this may be improved.

Drs Sophie Schlosser-Hupf and Jonas Staudacher discuss UEG‘s efforts to encourage collaboration and consensus for ...

A new nuclear medicine and molecular radiotherapy suite is streamlining and personalising cancer care, as Professor Jon ...

Rapid Response Systems (RRS) used by hospitals to stabilise in-patient deterioration in children varies considerably between European countries and hospitals. A new study has revealed significant ...